Two new bulk manufacturing facilities will come online by 2023 to feed the “incredible†global demand for HPV vaccine Gardasil, says Merck & Co. CEO Ken Frazier. Merck & Co. – known as MSD outside of North America – has for some time highlighted the human papillomavirus (HPV) vaccines Gardasil and Gardasil 9 as products with dominant near-term commercial potential. While the two vaccines pulled in $3.2 billion (€2.9 billion) in global sales in 2018, the Big Biopharma firm has spoken…
Waters Corporation will add an automated software system and robotics technology through the acquisition of Swiss biotech firm Andrew Alliance. Life sciences chromatography and measurement company Waters Corporation has not divulged the financial details of the deal, but a company spokesman said it significantly bolsters its lab tech portfolio through the addition of automated technologies. “Andrew Alliance’s cloud-native software platform and user interface dramatically improves the use of automation technology, enabling more scientists to realize the advantages of repeatability and…